Elham Hakimizadeh

Elham Hakimizadeh

Auto-generated profile, based on publicly available information

Elham Hakimizadeh

Physiology-Pharmacology Research Center, Rafsanjan University of Medical Sciences, Rafsanjan, Iran

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2017 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Closed access
GBGholamreza Bazmandegan
Gholamreza Bazmandegan
MBMohammad Taher Boroushaki
Mohammad Taher Boroushaki
ASAli Shamsizadeh
Ali Shamsizadeh
FAFatemeh Ayoobi
Fatemeh Ayoobi
EHElham Hakimizadeh
Elham Hakimizadeh
MAMohammad Allahtavakoli
Mohammad Allahtavakoli

1 August 2017
Verified
Journal Article
Open access
PDF file
EHElham Hakimizadeh
Elham Hakimizadeh
ASAli Shamsizadeh
Ali Shamsizadeh
ARAli Roohbakhsh
Ali Roohbakhsh
MAMohammad Kazemi Arababadi
Mohammad Kazemi Arababadi
MHMohammad Reza Hajizadehi
Mohammad Reza Hajizadehi
MAMohammad Allahtavakoli
Mohammad Allahtavakoli
Objective(s): Stroke is known as a main cause of mortality and prolonged disability in adults. Both transient receptor potential V1 (TRPV1) channels and toll-like receptors (TLRs) are involved in mediating the inflammatory responses. In the present study, the effects of TRPV1 receptor activation and blockade on stroke outcome and gene expression of TLR2 and TLR4 were assessed following permanent middle cerebral artery occlusion in rats Materials and Methods: Eighty male Wistar rats were divided into four groups as follows: sham, vehicle, AMG9810 (TRPV1 antagonist) -treated and capsaicin (TRPV1 agonist) -treated. For Stroke induction, the middle cerebral artery was permanently occluded and then behavioral functions were evaluated 1, 3 and 7 days after stroke. Results: TRPV1 antagonism significantly reduced the infarct volume compared to the stroke group. Also, neurological deficits were decreased by AMG9810 seven days after cerebral ischemia. In the ledged beam-walking test, the slip ratio was enhanced following ischemia. AMG9810 decreased this index in stroke animals. However, capsaicin improved the ratio 3 and 7 days after cerebral ischemia. Compared to the sham group, the mRNA expression of TLR2 and TLR4 was significantly increased in the stroke rats. AMG9810 Administration significantly reduced the mRNA expression of TLR2 and TLR4. However, capsaicin did not significantly affect the gene expression of TLR2 and TLR4. Conclusion: Our results demonstrated that TRPV1 antagonism by AMG9810 attenuates behavioral function and mRNA expression of TLR2 and TLR4. Thus, it might be useful to shed light on future therapeutic strategies for the treatment of ischemic stroke.

1 January 2013 in Clinical Laboratory
Verified
Journal Article
Closed access
ZJZahra Jamali
Zahra Jamali
MNMahmood Nazari
Mahmood Nazari
HKHossein Khoramdelazad
Hossein Khoramdelazad
EHElham Hakimizadeh
Elham Hakimizadeh
MMMehdi Mahmoodi
Mehdi Mahmoodi
NPNahideh Poor
Nahideh Poor
Background: Type-1 diabetes (T1D) is defined as a heterogeneous autoimmune disease. Immune system related factors are important in the pathogenesis of T1D. Chemokines are important factors in the pathogenesis of several autoimmune diseases, including T1D. They are potent chemotactic cytokines with various functions such as maturation, trafficking of leukocytes, angiogenesis, and homing of stem cells. Therefore, the current study was aimed to examine whether expression of CC chemokines CCL2, CCL5, and CXCL11 is associated with disease duration and complications in Iranian T1D patients. Methods: In this experimental study, blood samples were collected from 108 T1D patients and 189 healthy controls in EDTA pre-coated tubes. The serum levels of CC chemokines were measured by ELISA. Demographic data were also collected along with experimental examinations in a questionnaire which was designed specifically for this study. Results: Results of the present study demonstrated that the expression of CCL2 was decreased while CCL5 and CCL11 were increased in T1D patients in comparison to controls. These results demonstrated that CCL2, CCL5, and CCL11 were elevated in T1D patients with duration of disease. Again, our findings demonstrated that CCL2, CCL5, and CCL11 were elevated in T1D patients with age. But there was not a significant difference between circulating level of CC chemokines studied in T1D patients regarding their gender and they have followed a similar pattern of expression in both genders. Our findings also showed that all three CC chemokines were elevated in T1D patients suffering from diabetes complications. Conclusions: According to the results of our study, elevated levels of CCL5 and CCL11 are in parallel with decreased level of CCL2 and are useful tools in the differential diagnosis of T1D from other types of metabolic disorders. Elevated levels of these CC chemokines probably could be implicated as predictive factors for occurrence of T1D complications. These results may also re-emphasize the prominent therapeutic role(s) of these CC chemokines in control of either T1D or its associated complications.

13 April 2018 in Acta Chirurgica Belgica
Verified
Journal Article
Closed access
FDFereshteh Dehnamaki
Fereshteh Dehnamaki
AKAkbar Karimi
Akbar Karimi
APAli Asghar Pilevarian
Ali Asghar Pilevarian
IFIman Fatemi
Iman Fatemi
EHElham Hakimizadeh
Elham Hakimizadeh
GBGholamreza Bazmandegan
Gholamreza Bazmandegan
Background: Cisplatin (CP) is a synthetic and anticancer drug, and one of the major side effects of CP is nephrotoxicity. This study was done to evaluate the renoprotective effects of troxerutin (Tro) in nephrotoxicity induced by CP in male mice. Methods: In this experimental study, 28 male mice were divided randomly into four groups. Mice were treated with CP (20 mg/kg, i.p.) then Tro (75 and 150 mg/kg/day, po) was administered for three consecutive days. Blood samples were collected to determine serum creatinine (Cr) and blood urea nitrogen (BUN) levels. The kidney tissues were used for histological examination and biochemical assays. Malondialdehyde (MDA) level, superoxide dismutase (SOD) and glutathione peroxidase (GPx) activity were assessed in renal tissue. Results: Results showed a significant increase in the Cr, BUN and MDA levels and a significant decrease in the renal SOD and GPx activity by CP administration. Treatment with Tro for three consecutive days attenuated these changes. Also, the renoprotective effect of the Tro was confirmed by the histological examination of the kidneys. Conclusions: Our results demonstrated that Tro has protective effects against CP-induced nephrotoxicity through improving the biochemical indices and the oxidative stress parameters.

11 August 2012 in Inflammation
Verified
Journal Article
Closed access
PDF file
MKMojgan Noroozi Karimabad
Mojgan Noroozi Karimabad
MAMohammad Kazemi Arababadi
Mohammad Kazemi Arababadi
EHElham Hakimizadeh
Elham Hakimizadeh
HDHassan Yousefi Daredori
Hassan Yousefi Daredori
MNMahmood Nazari
Mahmood Nazari
DKDerek Kennedy
Derek Kennedy

23 March 2017 in Fundamental & Clinical Pharmacology
Verified
Journal Article
Closed access
PDF file
EHElham Hakimizadeh
Elham Hakimizadeh
ASAli Shamsizadeh
Ali Shamsizadeh
ARAli Roohbakhsh
Ali Roohbakhsh
MAMohammad Kazemi Arababadi
Mohammad Kazemi Arababadi
MHMohammad R. Hajizadeh
Mohammad R. Hajizadeh
MAMohammad Allahtavakoli
Mohammad Allahtavakoli